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There is some confusion about the deﬁnition of dry mouth in
the literature because the terms “xerostomia” and “salivary
gland hypofunction (SGH)” have been used interchangeably
in relation to the subjective complaints and objective aspects
of dry mouth [10,23,24]. Xerostomia is the subjective symp-
tom of dry mouth (this could be a result of a qualitative
change in saliva). It is a sensation that is assessed only by1016/j.sdj.2014.12.001
blished by Elsevier B.V.
uthor. Tel.: þ64 2040052977.
enephant@yahoo.com.sg (N.D. Ying Joanna).directly questioning the individual [7]. On the other hand, the
objective sign of dry mouth is salivary gland hypofunction, in
which the quantity of saliva produced is lowered. It can be
determined by sialometry [21].Measuring dry mouth
Determining the epidemiology of dry mouth is complex due
to (1) unclear deﬁnitions for dry mouth being used; (2) the
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samples used in most studies tending to be institutionalised
older people, who are often on multiple medications (which
can confound its investigation). The measurement of xeros-
tomia and salivary gland hypofunction will be discussed
separately.
Xerostomia is subjective, and therefore questions must be
used to assess xerostomia. The subjective symptom of dry
mouth, xerostomia, can be measured by a (1) single-item
question, or (2) multi-item approaches, including (a) batteries
of items, or (b) summated rating scales. An example of a
single-item question is “Does your mouth feel dry?” [20].
There are limitations to this method in capturing the severity
and variability of xerostomia. Such a single-item question
inevitably categorises a patient as xerostomic or non-
xerostomic according to an arbitrary cut-off point [10]. More-
over, the respondent will be likely to wonder whether the
question refers to “now”, or “usually?” [35]. A better example
of a single-item question is “How often does your mouth feel
dry?”, with a range of possible responses from ‘ever’ to
‘always’. It is used as a validity check in the Xerostomia
Inventory (XI), a summated rating scale [31]. The multi-item
approaches include (a) batteries of items; and (b) summated
rating scales. Batteries are a list of items with a ‘yes’/‘no’
response format. These items are usually questions asked
about the experiences with regard to dry mouth-related
problems or behaviours undertaken to alleviate dry mouth.
For example, Locker used a list of seven questions and a
simple ‘yes’/‘no’ response format to group nursing home
residents into three categories: no xerostomia (0 positive
responses); mild xerostomia (1–2); or marked xerostomia
(3–7) [15]. Batteries of items can be useful for exploring the
determinants of xerostomia. However, they may not relate to
the experience of dry mouth with just a ‘yes’/‘no’ response.
A summated rating scale is a multi-item scale that is a more
sophisticated reﬁnement of the item battery. For example,
the XI comprises 11 items (each response is given a numerical
value ranging from 1 to 5 according to its severity) aimed to
capture the broad experience of xerostomia [31]. So far, the XI
is the most comprehensive measure that addresses the
individual awareness and the consequences of xerostomia.
Moreover, it has been translated into several languages and
recently shortened into a validated 5-item scale [34].
SGH is an objective sign that can be measured clinically.
The normal daily production of saliva is between 0.5 and 1.5 l.
The three major salivary glands (parotid, submandibular and
sublingual) contribute to 90% of total salivary ﬂow. The minor
salivary glands contribute to the remaining 10% of salivary
ﬂow [22]. The secretions of the parotid glands contribute
mostly to stimulated saliva that is in the mouth for about 2 h
each day for alimentary functions [28]. The submandibular
and sublingual glands are the main contributors to the
unstimulated salivary ﬂow that is present in the mouth for
the majority of each day to lubricate and protect the oral
mucosa [12]. SGH can be estimated by measuring stimulated
or unstimulated salivary ﬂow. Salivary stimulation is com-
monly achieved using citric acid or chewing of a piece of
parafﬁn. Unstimulated salivary ﬂow is more representative of
the in vivo situation. Salivary ﬂow can be evaluated by
collecting saliva from individual glands or by assessing wholesalivary ﬂow (total secretions of major and minor glands).
Whole salivary ﬂow (usually using the spit technique) is a
more practical method to collect saliva [32]. Because salivary
ﬂow varies throughout the day [5], the objective of salivary
ﬂow measurement is to replicate consistency within the
same patient. A base reference recording to compare within
patient is ideal [11]. An unstimulated whole salivary ﬂow rate
of o0.1 ml/min or a stimulated ﬂow rate of o0.5 ml/min is
considered to be less than normal [27].The epidemiology of dry mouth
Some studies assume that everyone who experiences xeros-
tomia has SGH, and vice versa. The evidence suggests that
the two are not necessarily concurrent. Prevalence estimates
for dry mouth may vary and are dependent on factors such as
the nature of the sample (age, gender, health etc.) and the
case deﬁnitions used. The relationship between xerostomia
and SGH is complex. Logically, xerostomia can occur due to a
reduction in salivary ﬂow in SGH, but both the subjective
(xerostomia) and objective (SGH) components are known to
occur independently of each other [14]. The few studies
conducted on both xerostomia and SGH within the same
population show that the two are largely separate conditions.
In a systemtic review, the prevalence of xerostomia preva-
lence ranged from 8% to 42%, while the prevalence of SGH
prevalence ranged from 12% to 47%. The prevalence of both
conditions existing together is only about 2% to 6% [10].
Similarly, in a longitudinal study of a population-based
sample of 700 older South Australians, the prevalence of
xerostomia was 21% and the prevalence of SGH was 22%, but
only 6% of participants (or one in six of those with either
conditions) had both conditions [30].
The variability in prevalence estimates for xerostomia due
to different questionnaire formats and sample selection bias
has been addressed in a systematic review by Orellana et al.
(2006). Based on mainly elderly Scandinavian population
samples, the reported prevalence of xerostomia has ranged
from 0.9% to 64.8%. That variation may be explained as a
consequence of differences in the measurement process and
in case deﬁnitions. The review criticised the lack of consen-
sus in the literature in the deﬁnition of xerostomia, and
showed how the different types of single-item questions used
may yield different prevalence estimates in the same
population.
Even though it has been generally accepted that ageing
has no signiﬁcant impact on salivary ﬂow rates, the preva-
lence of xerostomia is greater in older people. This may be at
least partly due to the polypharmacy experienced with a
concurrent increase in age-related medical conditions [37].
The misconception that xerostomia affects only older people
has been challenged by ﬁndings from the Dunedin Multi-
disciplinary Health and Development Study, a longitudinal
study of health and behaviour in a complete birth cohort,
where xerostomia was reported in 10% of the 972 participants
at age 32 [33].
In older adults, there is a sex difference in xerostomia,
whereby the reported prevalence of xerostomia is lower in
men (10–26%) than in women (10–33%) [10]. There is no
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suggests that there may be some changes associated with
menopause, resulting in a greater experience of dry mouth in
older women [1].
In general, xerostomia and SGH affect a substantial min-
ority of the population, especially in older people. As the
global population continues to age [17], dry mouth will
become an increasingly prominent problem in the future.The aetiology of dry mouth
The common causes of dry mouth include xerogenic drugs,
radiotherapy to the head and neck for cancer, and systemic
diseases such as various connective tissue disorders [9].
Xerogenic drugs are the most common cause of dry mouth
investigated in epidemiological studies, and it is an area
which has been accompanied by the greatest number of
avoidable mistakes [35]. A look at dry mouth-inducing med-
ications reveals an almost inexhaustible list. These drugs
usually have anticholinergic or sympathomimetic actions
that affect the neural control of salivary glands, a cytotoxic
effect on salivary glands, or a diuretic effect that depletes
ﬂuids [25]. Sreebny and Schwartz identifed more than 400
drugs in 42 drug categories which they asserted were capable
of inducing xerostomia or SGH [27]. The utility of such broad
lists may be limited because most of the categories of
medication included are based on case reports and clinicians'
opinions instead of the ﬁndings of clinical or epidemiological
studies. There is no indication of whether the medications
listed cause xerostomia or SGH, and there is a lack of
information on the xerogenicity of each speciﬁc medication,
whether alone or in combination. Analysing the xerogenicity
of medications is complicated by the difﬁculties of capturing
information on medication exposure and choosing the ana-
lytical approach to be taken. Furthermore, polypharmacy is
common in older people, and dry mouth may be a side-effect
of the underlying medical conditions being treated [32].
Irradiation for malignant tumours in the head and neck
region can cause dry mouth by direct damage to the salivary
glands. Systemic diseases such as diabetes mellitus and
chronic renal failure can result in dehydration and hence
dry mouth. Systemic diseases that affect the salivary glands
can cause salivary dysfunction, resulting in dry mouth. These
include sarcoidosis, hepatitis C virus infection, and Sjögren's
syndrome. The common aetiology of dry mouth is sum-
marised in Table 1 [9].
In addition, there are physiological causes of dry mouth,
such as anxiety (due to sympathetic activity), mouthbreath-
ing, and (rarely) salivary gland agenesis [25]. Dry mouth in a
patient can be due to more than one factor. For example, in aTable 1 – Causes of dry mouth (after [9]).
Medications Antihistamine, Antihypertensives, Antidepres
Muscle relaxants, Diuretics, Anticonvulsants,
Sjögren's syndrome Primary and secondary
Connective tissue
diseases
Rheumatoid Arthritis, Systemic Lupus Erythe
Other conditions Radiotherapy, Chronic Active Hepatitis, HIV,
Type 1 and 2patient with a chronic systemic disease such as Sjögren's
syndrome, depression can be a commonly associated issue
[38,39]. In such a scenario, dry mouth in the patient may be
due to the salivary gland dysfunction, the anti-depressant-
induced dry mouth, or the depression itself [2].The impact of dry mouth
With an understanding of the prevalence and aetiology of dry
mouth, this next section will discuss the effects of dry mouth.
These include physical, emotional, and social impacts. The
function of saliva needs to be explained in order to compre-
hend the effects of chronic dry mouth. In healthy adults, up
to 1.5 l of saliva is produced daily. Salivary function can be
organised into ﬁve major categories that serve to maintain
oral health and create ecologic balance: (1) lubrication and
protection; (2) buffering action and clearance; (3) mainte-
nance of tooth integrity; (4) antibacterial activity; and (5) taste
and digestion. Unstimulated saliva keeps the oral mucosa
moist and maintains oral health. Stimulated saliva that is
produced in response to sensory stimuli (together with
mechanical chewing) aids in the digestion process. Saliva
also facilitates speech, cleanses food residues in the mouth,
enhances taste, and neutralises potentially damaging food
acids [11]. The physical impact of dry mouth is drastic and
can manifest in a range of signs and symptoms. These are
summarised in Table 2 (Soto-Rojas and Kraus, 2002).
The impact of dry mouth extends beyond the oral cavity
into the daily lives of sufferers. One way of assessing this is
by examining the effect of dry mouth on the oral-health-
related quality of life (OHRQoL) of sufferers [16]. A study of
225 institutionalised older people in Toronto [15] used two
different OHRQoL scales the General Oral Health Assessment
Index, or GOHAI; [3], and the short-form Oral Health Impact
Proﬁle, or OHIP-14 [26]. It found xerostomia be an important
inﬂuence on the rOHQoL. In a study of a Swedish older
population [8], both xerostomia and SGH were found to be
signiﬁcantly associated with OHRQoL. In the Dunedin study,
xerostomia was found to be strongly and independently
associated with poorer OHRQoL among 32-year-olds. This
ﬁnding suggested that xerostomia is not a trivial condition for
anyone, whether relatively healthy young adults or institu-
tionalised older adults ([33]a). More investigation aimed at
improving the understanding of the impact of dry mouth on
people's daily lives is essential. Qualitative research is one
approach to improve knowledge in this area because this
paradigm of research is based on the in-depth understanding
of a phenomenon. The qualitative methods (such as diaries
and interviews) employed allow for insight into the patient
experience of dry mouth.sants, Anticholinergics, Antipsychotics, Sedatives, Analgesics,
etc.
matosus, Systemic Sclerosis, Mixed connective tissue disease
Graft vs Host disease, Renal Dialysis, Anxiety, Depression, Diabetes
Table 2 – Signs and symptoms of oral dryness (after Soto-
Rojas and Kraus (2002)).
Signs
Dry, cracked, and peeling lips; dry and coarse tongue
Cracks in the corners of the mouth
Dental decay, cervical or atypical (such as in incisal and cusp
areas)
Dental erosion
Erythematous tongue
Swelling of the salivary glands
Mucositis
Oral candidiasis
Oral ulcers
Symptoms
Difﬁculties while swallowing and chewing dry foods
Sensitivity to spicy foods
Altered, salty, bitter, and metallic taste in mouth
Burning sensation
Lack of (or diminished) taste perception
Pain in salivary glands
Coughing episodes
Voice disturbances/speech difﬁculties
Increased liquid intake
Nocturnal discomfort
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As mentioned, dry mouth has both a subjective (xerostomia)
and an objective component (SGH), which are assessed using
questionnaires and salivary measurements respectively.
A recent Dutch study has shown that it does not seem possible
to diagnose oral dryness by the mere visual inspection of
photographed tongues. It recommended that the correct diag-
nosis of dry mouth required further clinical investigation of the
oral cavity, along with saliva measurement [4].Table 3 – Overview of the management of dry mouth
(after [19]).
Manage underlying systemic conditions
Multidisciplinary management with other healthcare providers
Management of symptoms
Diet and habit modiﬁcations
Frequent and regular sips of water
Avoidance of dry, hard, sticky, acidic foods
Avoidance of excess caffeine and alcohol
Salivary substitutes and lubricants
Artiﬁcial saliva, gels, rinses, sprays, bedside humidiﬁer
(sleeping hours)
Sialogogues
Pilocarpine 5–10 mg orally TDS
Cevimeline 30 mg orally TDS
Acupuncture
Management of the consequences of dry mouth
Prevention
Increased frequency of dental examination
Topical ﬂuoride application
Treatment of oral conditions
Dental caries – Restoration, topical ﬂuoride
Oral candidiasis – Chlorhexidine rinse and antifungal
medication
Poor-ﬁtting prosthesis – Denture adhesives.The management of dry mouth
Dry mouth is not an easy condition to manage. The manage-
ment of dry mouth and its consequences will be discussed in
this section. In general, the goals in managing dry mouth are
to deal with the underlying systemic condition(s), alleviate
symptoms, and institute preventive measures. This may
involve increasing the amount of existing saliva or replacing
lost secretions in order to control the development of caries
and treat speciﬁc oral infections such as candidiasis [36].
In order to manage dry mouth, the underlying cause needs
to be understood (and rectiﬁed if possible). For example,
patients taking xerogenic medications may have the drugs
changed for an alternative if possible. However, this may be
impractical in view of the wide range of medications that
induce dry mouth, and the polypharmacy that is especially
common in the older population. Should the underlying
cause of dry mouth be a systemic disorder (such as diabetes
mellitus), treatment should be aimed at the systemic disease.
Synthetic saliva substitutes (such as dry mouth gel or
sprays) contain carboxymethylcellulose, a mucopolysaccharide,
glycerate polymer base or mucins; all of these can provide
temporary mucosal wetting. More recently, 1% malic acid sprayhas been shown to be an effective topical sialogogue to improve
xerostomia in patients who are on antidepressants and anti-
hypertensive medications [18]. Furthermore, an intra-oral elec-
trostimulation device was found to alleviate oral dryness,
discomfort, speech and sleeping difﬁculties, and to increase
salivary output in Sjögren's patients [29]. However, this can
work only with patients who have residual salivary gland
function, and the comfort and practicality of using such devices
need to be considered. Sugar-free candies and chewing gums
that contain xylitol can be used to stimulate salivary ﬂow.
Patients with dry mouth can also make adjustments to their
diet in order to avoid dry or acidic food, and they can sip water
with (and between) their meals. Raising patient awareness is
also important, so that they can avoid factors that may increase
oral dryness (such as caffeine or alcohol), and keep the mouth
moist. Sialologues that are cholinergic drugs (such as pilocar-
pine) can be prescribed to promote saliva production [6,19].
These are effective only in patients with sufﬁcient exocrine
tissue, and may have adverse effects such as nausea, vomiting,
and affect pulmonary and cardiac functions [37].
There are measures which can be taken to prevent the
adverse consequences of dry mouth. These include adopting
a non-cariogenic diet, a high level of oral hygiene, and the
regular use of topical ﬂuoride agents (toothpaste, gels, rinses,
varnishes), and casein phosphopeptide-amorphous calcium
phosphate. Dental examinations every 4–6 months (with
accompanying radiographs) are also recommended, followed
by any required treatment.
There is no cure for dry mouth; rather, there is only
palliative management to alleviate the symptoms. Although
acupuncture has been noted to be effective in the treatment
of dry mouth after head and neck radiotherapy [13], further
research needs to be done in this area. The measures to
manage dry mouth are summarised in Table 3 [19].
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cause of dry mouth, the symptoms of dry mouth (diet and
habit modiﬁcations, salivary substitutes, sialogogues, acu-
puncture) and the underlying consequences of dry mouth
(prevention and treatment). The items in the Table act as a
general guideline only, because there are different brands and
medications available in different countries. Many of these
strategies to alleviate the symptoms of dry mouth may only
have a short-term effect. Moreover, it is imperative for
clinicians to understand that each individual needs to tailor
the management of dry mouth to suit their lifestyle and
preferences.Conclusion
In conclusion, dry mouth is a complex condition that will
become increasingly prevalent in view of the aging popula-
tion. Much research has been done to quantify and under-
stand the cause of dry mouth. Its impact on sufferers is
pertinent in view of its negative effect on OHRQoL and the
lack of cure. It is crucial for clinicians to recognise that dry
mouth is not a trivial condition, and it is especially relevant
to the older population.
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